HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.210

+0.0350.68%

Volume:3.98M

Turnover:21.03M

Market Cap:2.04B

PE:-9.47

High:5.375

Open:5.280

Low:5.185

Close:5.175

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:1.64

T/O Rate:1.03%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.550

ROE:-125.57%

ROA:-44.55%

PB:6.54

PE(LYR):-9.47

PS:-152.42

Loading ...

Overview Company News Filings

派格生物医药-B计划委任容诚香港为审计机构

PEGBIO CO-B Proposes Appointment of Grant Thornton Hong Kong as New Auditor

PegBio Reports No Change in Share Capital for August 2026; Confirms Adequate Public Float

Bulletin Express

PegBio Signs Material Transfer Agreement with SN BioScience

MT Newswires Live

Pegbio Enters Joint Research and Development Collaboration with SN Bioscience

Beyond Outreach: Global Innovators Are Actively Seeking Out PEGBIO's Drug Assets

Pegbio Co - Collaboration to Combine Sna Platform with Three Pegbio Peptide Candidates Including Apgp6

THOMSON REUTERS

Pegbio Co - Potential for Follow-on Collaboration Including Licensing or Co-Development

THOMSON REUTERS

Pegbio Co - Joint R&D Collaboration with Sn Bioscience

THOMSON REUTERS

PB-2312 Enters the Arena Against Retatrutide and Efruxifermin: What New Card Does PEGBIO Hold?

PegBio interim loss deepens to RMB216 million amid ramp-up in R&D; first HK$61 million royalty marks progress in Paidakang® rollout

Bulletin Express

PEGBIO CO-B Unveils Interim Results with R&D Spending Reaching 110 Million Yuan

Pegbio Co Hy Loss Rmb216.2 Mln

THOMSON REUTERS

PegBio FY26 H1 Net Loss More than Doubles to RMB 216.2 Million

Lexaria Signs Material Transfer Agreement with PegBio to Test DehydraTECH with GLP-1 Molecule

PegBio Schedules 25 August 2026 Board Meeting to Approve 1H26 Interim Results

Bulletin Express

PegBio Schedules Board Meeting to Review Interim Results

Movement Alert｜PEGBIO CO-B Rises 8.82% in Regular Trading, Paidakang Commercialization Triggers Second Milestone Payment of HK$49 Million

Movement Alert｜PEGBIO CO-B Rises 8.93% in Regular Trading, Trading at HK$5.745

PegBio Records Stable Share Capital and Confirms Adequate Public Float for July 2026

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/02565/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.21,"timestamp":1790755707004,"preClose":5.175,"halted":0,"volume":3981650,"delay":0,"changeRate":0.006763285024154617,"floatShares":386000000,"shares":391000000,"eps":-0.55,"marketStatus":"Closed National Day","change":0.035,"latestTime":"09-30 16:08:27","open":5.28,"high":5.375,"low":5.185,"amount":21028059,"amplitude":0.036715,"askPrice":5.215,"askSize":65350,"bidPrice":5.21,"bidSize":19250,"shortable":3,"etf":0,"ttmEps":-0.982664,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.175,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.642791422971399,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-44.55%","roe":"-125.57%","lyrEps":-0.55,"volumeRatio":1.642791422971399,"shares":391000000,"dividePrice":0,"high":5.375,"amplitude":0.036715,"preClose":5.175,"low":5.185,"week52Low":4.94,"pbRate":"6.54","psRate":"-152.42","week52High":77,"institutionHeld":0,"latestPrice":5.21,"committee":-0.544917,"eps":-0.55,"divideRate":0,"volume":3981650,"delay":0,"ttmEps":-0.982664,"open":5.28,"prevYearClose":69,"prevWeekClose":5.36,"prevMonthClose":5.21,"prevQuarterClose":5.21,"fiveDayClose":5.59,"twentyDayClose":5.585,"sixtyDayClose":5.52},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-09-30","current":-5.301914,"percent":0.993827,"low":-87.782868,"twenty":-72.093156,"median":-41.864246,"eighty":-10.258097,"high":-5.123552,"avg":-41.000092,"sd":28.902031,"marketCap":2037586881},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750},{"date":"2026-08-28","current":-5.766342,"twenty":-72.790068,"median":-56.898206,"eighty":-11.368021,"marketCap":2225310817},{"date":"2026-09-04","current":-5.809614,"twenty":-72.647581,"median":-53.43223,"eighty":-11.296065,"marketCap":2242909936},{"date":"2026-09-11","current":-5.877658,"twenty":-72.523005,"median":-49.422967,"eighty":-11.223589,"marketCap":2272241800},{"date":"2026-09-18","current":-5.854834,"twenty":-72.380908,"median":-46.448991,"eighty":-11.082977,"marketCap":2266375427},{"date":"2026-09-25","current":-5.425683,"twenty":-72.097427,"median":-43.047517,"eighty":-10.604864,"marketCap":2096250611},{"date":"2026-09-30","current":-5.264024,"twenty":-72.093156,"median":-41.864246,"eighty":-10.258097,"marketCap":2037586881}],"updateTime":1790832689276},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1110441396","title":"派格生物医药-B计划委任容诚香港为审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=1110441396","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110441396?lang=en_us&edition=fundamental","pubTime":"2026-09-21 07:50","pubTimestamp":1789948243,"startTime":"0","endTime":"0","summary":"派格生物医药-B（02565）对外发布公告，因未能与毕马威会计师事务所（下称毕马威）就截至2026年12月31日止年度的审计费用达成一致意见，经公司董事会审计委员会推荐，提议解除毕马威的审计职务。董事会建议委任容诚（香港）会计师事务所有限公司（下称容诚香港）为截至2026年12月31日止财政年度的新任核数师，以填补因建议解聘而产生的临时空缺，任期将持续至下一届股东周年大会闭幕之时。此项审计机构变更事宜，尚需在拟召开的临时股东大会上通过相关决议后，方可正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","161726","02565","399441","BK4581","BK4585","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195564019","title":"PEGBIO CO-B Proposes Appointment of Grant Thornton Hong Kong as New Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=1195564019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195564019?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:30","pubTimestamp":1789741823,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) has released an announcement stating that, due to a failure to reach an agreement with KPMG on audit fees for the fiscal year ending December 31, 2026, the company has proposed to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","399441","BK4585","XBI","BK1161","BK4588","BK4581","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152624399","title":"PegBio Reports No Change in Share Capital for August 2026; Confirms Adequate Public Float","url":"https://stock-news.laohu8.com/highlight/detail?id=1152624399","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152624399?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:24","pubTimestamp":1788431096,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. released its Monthly Return for Equity Issuer covering the period ended 31 August 2026, showing a stable capital structure and continued compliance with Hong Kong public-float...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664158578","title":"PegBio Signs Material Transfer Agreement with SN BioScience","url":"https://stock-news.laohu8.com/highlight/detail?id=2664158578","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664158578?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:47","pubTimestamp":1788346064,"startTime":"0","endTime":"0","summary":"PegBio  entered into a material transfer agreement with SN BioScience, according to a Wednesday Hong Kong bourse filing.Under the agreement, the parties will combine SN BioScience's proprietary Serinol Nucleic Acids long-acting drug delivery platform with three innovative peptide drug candidates for metabolic diseases developed by PegBio.The parties will research formulation and long-acting delivery to evaluate the in vivo performance, pharmacokinetic characteristics and further development potential of the candidate-platform combinations.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","BK4191","LU2242644610.SGD","SN","02565","LU0029874061.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664694813","title":"Pegbio Enters Joint Research and Development Collaboration with SN Bioscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2664694813","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664694813?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:24","pubTimestamp":1788344653,"startTime":"0","endTime":"0","summary":"BRIEF-Pegbio Enters Joint Research And Development Collaboration With SN BioscienceSept 2 (Reuters)-PegBio Co Ltd2565.HK:COLLABORATION TO COMBINE SNA PLATFORM WITH THREE PEGBIO PEPTIDE CANDIDATES INCL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T173:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106215002","title":"Beyond Outreach: Global Innovators Are Actively Seeking Out PEGBIO's Drug Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1106215002","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106215002?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:32","pubTimestamp":1788341550,"startTime":"0","endTime":"0","summary":"For any innovative drug developer, the true value of international alliances goes far beyond simply tallying up signed agreements. The more critical questions are: Why do these partnerships happen,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664974508","title":"Pegbio Co - Collaboration to Combine Sna Platform with Three Pegbio Peptide Candidates Including Apgp6","url":"https://stock-news.laohu8.com/highlight/detail?id=2664974508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664974508?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:01","pubTimestamp":1788339674,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T173:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897463","title":"Pegbio Co - Potential for Follow-on Collaboration Including Licensing or Co-Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897463?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:01","pubTimestamp":1788339674,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T173:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897448","title":"Pegbio Co - Joint R&D Collaboration with Sn Bioscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897448","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897448?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:01","pubTimestamp":1788339674,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T173:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199128434","title":"PB-2312 Enters the Arena Against Retatrutide and Efruxifermin: What New Card Does PEGBIO Hold?","url":"https://stock-news.laohu8.com/highlight/detail?id=1199128434","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199128434?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:02","pubTimestamp":1787652157,"startTime":"0","endTime":"0","summary":"Viewing PEGBIO CO-B (02565) merely as a company with a single GLP-1 product may no longer be sufficient. The 2026 interim report warrants a fresh look from the capital markets, not for an increased...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161","IE00BLDYK493.USD","BK4211","IE00B64QTZ34.USD","PB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109220815","title":"PegBio interim loss deepens to RMB216 million amid ramp-up in R&D; first HK$61 million royalty marks progress in Paidakang® rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=1109220815","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109220815?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:48","pubTimestamp":1787647729,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PegBio) reported a net loss of RMB216.20 million for the six months ended 30 June 2026, more than double the RMB93.67 million loss booked a year earlier. Basic and diluted loss per...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"PegBio interim loss deepens to RMB216 million amid ramp-up in R&D; first HK$61 million royalty marks progress in Paidakang® rollout","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146455709","title":"PEGBIO CO-B Unveils Interim Results with R&D Spending Reaching 110 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1146455709","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146455709?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:40","pubTimestamp":1787647222,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) has released its interim financial report for the six months ended June 30, 2025. The company recorded a net loss from other operations of RMB 11.27 million, with research and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","161726","XBI","BK1161","02565","BK4581","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662829577","title":"Pegbio Co Hy Loss Rmb216.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662829577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662829577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:32","pubTimestamp":1787646754,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nPLX138VLS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782985","title":"PegBio FY26 H1 Net Loss More than Doubles to RMB 216.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782985","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662782985?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:31","pubTimestamp":1787646712,"startTime":"0","endTime":"0","summary":"PegBio FY26 H1 net loss more than doubles to RMB 216.2 millionPegBio posted an operating loss of RMB 214.23 million for the six months ended June 30, 2026, worsening from RMB 92.14 million.Net loss wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL9HZ1KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157840","title":"Lexaria Signs Material Transfer Agreement with PegBio to Test DehydraTECH with GLP-1 Molecule","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157840","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157840?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:00","pubTimestamp":1786626053,"startTime":"0","endTime":"0","summary":"Lexaria signs material transfer agreement with PegBio to test DehydraTECH with GLP-1 moleculeLexaria entered a material transfer agreement with PegBio to test DehydraTECH with PegBio’s proprietary GLP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5fBfXZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","LEXX","BK1161","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141430077","title":"PegBio Schedules 25 August 2026 Board Meeting to Approve 1H26 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1141430077","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141430077?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:09","pubTimestamp":1786612170,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. announced that its board of directors will convene on 25 August 2026 to review and approve the Group’s interim financial results for the six months ended 30 June 2026. The meeting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659137998","title":"PegBio Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659137998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659137998?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:58","pubTimestamp":1786611536,"startTime":"0","endTime":"0","summary":"PegBio schedules board meeting to review interim resultsPegBio will hold a board meeting on Aug. 25, 2026.The board is set to review interim results for the six months ended June 30, 2026.Disclaimer:T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6k16WS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105232336","title":"Movement Alert｜PEGBIO CO-B Rises 8.82% in Regular Trading, Paidakang Commercialization Triggers Second Milestone Payment of HK$49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1105232336","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105232336?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:54","pubTimestamp":1786589673,"startTime":"0","endTime":"0","summary":"On August 13, PEGBIO CO-B rose 8.82% in regular trading, reaching HK$6.725, with turnover of approximately HK$90.85 million. The rally was driven by continued commercialization momentum of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110969594","title":"Movement Alert｜PEGBIO CO-B Rises 8.93% in Regular Trading, Trading at HK$5.745","url":"https://stock-news.laohu8.com/highlight/detail?id=1110969594","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110969594?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:53","pubTimestamp":1786085593,"startTime":"0","endTime":"0","summary":"On August 7, PEGBIO CO-B rose 8.93% in regular trading, trading at HK$5.745/share, with turnover of HK$45.43 million.Within the Biotechnology sector where PEGBIO CO-B belongs, the sector showed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143828487","title":"PegBio Records Stable Share Capital and Confirms Adequate Public Float for July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1143828487","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143828487?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:25","pubTimestamp":1785921915,"startTime":"0","endTime":"0","summary":"For the month ended 31 July 2026, PegBio Co., Ltd. reported no changes in its registered or issued share capital, according to the company’s monthly return submitted on 05 August 2026 to Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":105,"code":"91000000","status":"200"}]}}